zy1602 catalog nov2016 v2 - zydus pharmaceuticals · 2016-12-06 · 68382-0080-01 10mg 100 24...
TRANSCRIPT
New LaunchesAmantadine HCl Capsules, USPDextroamphetamine Sulfate Tablets, USPIndomethacin Capsules, USPNateglinide Tablets, USPSodium Phenylacetate/Sodium Benzoate Injection
(updated as of December 2016)
WINTER 2016
Product Catalog
zydusUSA.com
1 www.zydususa.com
NDC Strength Count Case Description/Imprint Code
Acetazolamide Extended-Release CapsulesAB-Rated to Diamox® Sequels
68382-0261-01 500mg 100 24 Capsule; Orange Opaque/White Opaque; EP/107
Acyclovir TabletsAB-Rated to Zovirax® Tablets
68382-0791-01 400mg 100 24 Round; White to Off-White; 791
68382-0791-05 400mg 500 12 Round; White to Off-White; 791
68382-0792-01 800mg 100 24 Oval; White to Off-White; 792
68382-0792-05 800mg 500 12 Oval; White to Off-White; 792
Amantadine HCl Capsules, USPAB-Rated to Symmetrel® Capsules
68382-0512-01 100mg 100 24 Capsules; Red/Red; 652
68382-0512-05 100mg 500 12 Capsules; Red/Red; 652
Amiodarone HCl TabletsAB-Rated to Cordarone® Tablets
68382-0227-14 200mg 60 24 Round; White to Off-White; Bisect, ZE 65
68382-0227-05 200mg 500 12 Round; White to Off-White; Bisect, ZE 65
Amlodipine Besylate TabletsAB-Rated to Norvasc® Tablets
68382-0121-16 2.5mg 90 24 Round; White to Off-White; Z/7
68382-0121-05 2.5mg 500 12 Round; White to Off-White; Z/7
68382-0122-16 5mg 90 24 Round; White to Off-White; Z3
68382-0122-05 5mg 500 12 Round; White to Off-White; Z3
68382-0123-16 10mg 90 24 Round; White to Off-White; Z5
68382-0123-05 10mg 500 12 Round; White to Off-White; Z5
Anastrozole TabletsAB-Rated to Arimidex® Tablets
68382-0209-06 1mg 30 24 Round; White; A7
68382-0209-10 1mg 1000 12 Round; White; A7
Atenolol Tablets, USPAB-Rated to Tenormin® Tablets
68382-0022-01 25mg 100 24 Round; White to Off-White; Z/65
68382-0022-10 25mg 1000 12 Round; White to Off-White; Z/65
68382-0023-01 50mg 100 24 Round; White to Off-White; Bisect, Z 66
68382-0023-10 50mg 1000 12 Round; White to Off-White; Bisect, Z 66
68382-0024-01 100mg 100 24 Round; White to Off-White; Z 67
68382-0024-10 100mg 1000 12 Round; White to Off-White; Z 67
2 www.zydususa.com
NDC Strength Count Case Description/Imprint Code
Azathioprine Tablets, USPAB-Rated to Imuran® Tablets
68382-0003-01 50mg 100 24 Round; Yellow, Bisect; ZC 59
68382-0003-05 50mg 500 12 Round; Yellow, Bisect; ZC 59
Benzonatate Capsules, USPAA-Rated to Tessalon® Perles
68382-0247-01 100mg 100 24 Round; Light Yellow; Z
68382-0247-05 100mg 500 12 Round; Light Yellow; Z
Buspirone HCl Tablets, USPAB-Rated to BuSpar® Tablets
68382-0180-01 5mg 100 24 Capsule-shaped; White to Off-White; Bisect, ZE 36
68382-0180-05 5mg 500 12 Capsule-shaped; White to Off-White; Bisect, ZE 36
68382-0181-01 10mg 100 24 Capsule-shaped; White to Off-White; Bisect, ZE 37
68382-0181-05 10mg 500 12 Capsule-shaped; White to Off-White; Bisect, ZE 37
68382-0182-01 15mg 100 24 Capsule-shaped; White to Off-White; Bisect, ZE 38/Trisect, 5 5 5
68382-0182-05 15mg 500 12 Capsule-shaped; White to Off-White; Bisect, ZE 38/Trisect, 5 5 5
68382-0183-14 30mg 60 24 Capsule-shaped; White to Off-White; Bisect, ZE 38/Trisect, 10 10 10
68382-0183-05 30mg 500 12 Capsule-shaped; White to Off-White; Bisect, ZE 38/Trisect, 10 10 10
Carvedilol TabletsAB-Rated to Coreg® Tablets
68382-0092-01 3.125mg 100 24 Round; White to Off-White; Z/1
68382-0092-05 3.125mg 500 12 Round; White to Off-White; Z/1
68382-0093-01 6.25mg 100 24 Round; White to Off-White; ZC40
68382-0093-05 6.25mg 500 12 Round; White to Off-White; ZC40
68382-0094-01 12.5mg 100 24 Round; White to Off-White; ZC41
68382-0094-05 12.5mg 500 12 Round; White to Off-White; ZC41
68382-0095-01 25mg 100 24 Round; White to Off-White; ZC42
68382-0095-05 25mg 500 12 Round; White to Off-White; ZC42
Dextroamphetamine Sulfate Tablets, USPAB-Rated to Dextrostat® Tablets
68382-0941-01 5mg 100 24 Round; Peach; "N" score "941"
68382-0942-01 10mg 100 24 Round; Pink; "N" score "942"
3 www.zydususa.com
NDC Strength Count Case Description/Imprint Code
Divalproex Sodium Capsules (Sprinkle)AB-Rated to Depakote® Sprinkle Capsules
68382-0106-01 125mg 100 24 Capsule; Blue/White; ZA66/125mg
68382-0106-10 125mg 1000 12 Capsule; Blue/White; ZA66/125mg
Divalproex Sodium Delayed-Release Tablets, USPAB-Rated to Depakote® Delayed-Release Tablets
68382-0031-01 125mg 100 24 Oval; White to Off-White; ZA08
68382-0031-05 125mg 500 12 Oval; White to Off-White; ZA08
68382-0032-01 250mg 100 24 Oval; White to Off-White; ZA07
68382-0032-05 250mg 500 12 Oval; White to Off-White; ZA07
68382-0033-01 500mg 100 24 Oval; White to Off-White; ZA06
68382-0033-05 500mg 500 12 Oval; White to Off-White; ZA06
Divalproex Sodium Extended-Release TabletsSame as Depakote® Extended-Release Tablets
68382-0314-01 250mg 100 24 Ovaloid; White; “a” logo HF
68382-0314-05 250mg 500 12 Ovaloid; White; “a” logo HF
68382-0315-01 500mg 100 24 Ovaloid; Gray; “a” logo HC
68382-0315-05 500mg 500 12 Ovaloid; Gray; “a” logo HC
Donepezil HCl Orally Disintegrating TabletsAB-Rated to Aricept ODT® OD Tablets
68382-0346-06 5mg 30 24 Round; White to Off-White; ZF14
68382-0347-06 10mg 30 24 Round; White to Off-White; ZF15
Doxycycline Monohydrate Capsules, USPAB-Rated to Monodox® Capsules
68382-0782-01 50mg 100 24 Capsule; Opaque Yellow/Opaque White; 782/Plain
68382-0707-18 100mg 50 24 Capsule; Opaque Yellow/Opaque Orange; 707/Plain
Duloxetine HCl Delayed-Release CapsulesAB-Rated to Cymbalta®
68382-0385-14 20mg 60 24 Capsule; Green/White; 241/20 mg
68382-0386-06 30mg 30 24 Capsule; Blue/Green; 242/30 mg
68382-0387-06 60mg 30 24 Capsule; Blue/White; 243/60 mg
4 www.zydususa.com
NDC Strength Count Case Description/Imprint Code
Etodolac Extended-Release TabletsAB-Rated to Lodine XL® Extended-Release Tablet
68382-0271-14 400mg 60 24 Oval; Orange; 271
68382-0271-01 400mg 100 24 Oval; Orange; 271
68382-0272-14 500mg 60 24 Oval; Grey; 272
68382-0272-01 500mg 100 24 Oval; Grey; 272
68382-0273-14 600mg 60 24 Oval; Blue; 273
68382-0273-01 600mg 100 24 Oval; Blue; 273
Etomidate Injection, USPAB-Rated to Amidate® Injection
68382-0545-07 2mg/mL 10 mL 24 SD vial, 10 vials per carton
68382-0545-08 2mg/mL 20 mL 12 SD vial, 10 vials per carton
Famotidine for Oral Suspension, USPAB-Rated to Pepcid® for Oral Suspension
68382-0444-05 40mg/5mL 50 mL 24 White to Off-White; Cherry-Mint fl avor
Fenofi brate TabletsSame as TriCor® Tablets
68382-0269-16 48mg 90 24 Oval; Yellow; “a” logo/FI
68382-0270-16 145mg 90 24 Oval; White; FO
Fenofi bric Acid Delayed-Release CapsulesSame as Trilipix® Delayed-Release Capsules
68382-0077-16 45mg 90 24 Capsule; Reddish-brown/Yellow; “a” logo/45
68382-0078-16 135mg 90 24 Capsule; Blue/Yellow; “a” logo/135
5 www.zydususa.com
NDC Strength Count Case Description/Imprint Code
Gabapentin TabletsAB-Rated to Neurontin® Tablets
68382-0204-01 600mg 100 24 Oval; White to Off-White; ZE72 bisect/bisect
68382-0204-05 600mg 500 12 Oval; White to Off-White; ZE72 bisect/bisect
68382-0205-01 800mg 100 24 Oval; White to Off-White; ZE71 bisect/bisect
68382-0205-05 800mg 500 12 Oval; White to Off-White; ZE71 bisect/bisect
Galantamine HBr Tablets, USPAB-Rated to Razadyne® Tablets
68382-0177-14 4mg 60 24 Round; Light Pink; 77/Z
68382-0178-14 8mg 60 24 Round; Off-White; 78/Z
68382-0179-14 12mg 60 24 Round; Off-White; 79/Z
Glipizide/Metformin HCl Tablets, USP AB-Rated to Metaglip® Tablets
68382-0184-01 2.5/250mg 100 24 Modifi ed Capsule-shaped; Pink; ZE68
68382-0185-01 2.5/500mg 100 24 Modifi ed Capsule-shaped; White; ZE67
68382-0186-01 5/500mg 100 24 Modifi ed Capsule-shaped; Pink; ZE66
Glyburide Tablets, USPAB-Rated to Micronase® Tablets
68382-0656-01 1.25mg 100 24 Round; White to Off-White; 656/bisect
68382-0657-01 2.5mg 100 24 Round; Light Yellow; 657/bisect
68382-0657-05 2.5mg 500 12 Round; Light Yellow; 657/bisect
68382-0658-01 5mg 100 24 Round; Light Green; 658/bisect
68382-0658-10 5mg 1000 12 Round; Light Green; 658/bisect
Glyburide/Metformin HCl Tablets, USPAB-Rated to Glucovance® Tablets
68382-0653-01 1.25/250mg 100 24 Capsule-shaped; White to Off-White; 653
68382-0654-01 2.5/500mg 100 24 Capsule-shaped; Tan to Scarlet Yellow; 654
68382-0654-05 2.5/500mg 500 12 Capsule-shaped; Tan to Scarlet Yellow; 654
Glyburide/Metformin HCl Tablets, USP continued on next page
6 www.zydususa.com
NDC Strength Count Case Description/Imprint Code
Glyburide/Metformin HCl Tablets, USP (continued)AB-Rated to Glucovance® Tablets
68382-0655-01 5/500mg 100 24 Capsule-shaped; Pale Yellow; 655
68382-0655-05 5/500mg 500 12 Capsule-shaped; Pale Yellow; 655
Haloperidol Tablets, USPAB-Rated to Haloperidol Tablets, USP
68382-0079-01 5mg 100 24 Capsule; Green; Partial Bisect, ZC 07
68382-0079-10 5mg 1000 12 Capsule; Green; Partial Bisect, ZC 07
68382-0080-01 10mg 100 24 Capsule; Light Green; Partial Bisect, ZC 08
68382-0081-01 20mg 100 24 Capsule; Coral; Bisect, ZC 09
Hydroxychloroquine Sulfate Tablets, USPAB-Rated to Plaquenil® Tablets
68382-0096-01 200mg 100 24 Capsule; White to Off-White; ZC38
68382-0096-05 200mg 500 12 Capsule; White to Off-White; ZC38
Indomethacin Capsules, USPAB-Rated to Indocin® Capsules
68382-0293-01 25mg 100 24 Capsule; Green/Green; 293/25 mg
68382-0293-10 25mg 1000 12 Capsule; Green/Green; 293/25 mg
68382-0294-01 50mg 100 24 Capsule; Green/Green; 294/50 mg
68382-0294-05 50mg 500 12 Capsule; Green/Green; 294/50 mg
Isosorbide Mononitrate Extended-Release TabletsAB-Rated to Imdur® Tablets
68382-0650-01 30mg 100 24 Oval; Reddish Pink; "N" bisect "30"/ Bisect
68382-0650-05 30mg 500 12 Oval; Reddish Pink; "N" bisect "30"/ Bisect
68382-0651-01 60mg 100 24 Oval;Yellow;"N" bisect "60"/ Bisect
68382-0651-05 60mg 500 12 Oval;Yellow;"N" bisect "60"/ Bisect
68382-0652-01 120mg 100 24 Oval; White, N120
7 www.zydususa.com
NDC Strength Count Case Description/Imprint Code
Lamotrigine TabletsAB-Rated to Lamictal® Tablets
68382-0006-01 25mg 100 24 Round; White to Off-White; Bisect, ZC 79
68382-0006-10 25mg 1000 12 Round; White to Off-White; Bisect, ZC 79
68382-0008-01 100mg 100 24 Round; White to Off-White; Bisect, ZC 80
68382-0008-10 100mg 1000 12 Round; White to Off-White; Bisect, ZC 80
68382-0009-14 150mg 60 24 Round; White to Off-White; Bisect, ZC 81
68382-0009-05 150mg 500 12 Round; White to Off-White; Bisect, ZC 81
68382-0010-14 200mg 60 24 Round; White to Off-White; Bisect, ZC 82
68382-0010-05 200mg 500 12 Round; White to Off-White; Bisect, ZC 82
Lansoprazole Delayed-Release Capsules, USP AB-Rated to Prevacid® Delayed-Release Capsules
68382-0543-06 15mg 30 24 Capsule; Opaque Pink/Opaque White; ZA-50/15mg
68382-0543-10 15mg 1000 12 Capsule; Opaque Pink/Opaque White; ZA-50/15mg
68382-0544-06 30mg 30 24 Capsule; Opaque Pink/Opaque White; ZA-51/30mg
68382-0544-16 30mg 90 24 Capsule; Opaque Pink/Opaque White; ZA-51/30mg
68382-0544-01 30mg 100 24 Capsule; Opaque Pink/Opaque White; ZA-51/30mg
68382-0544-10 30mg 1000 12 Capsule; Opaque Pink/Opaque White; ZA-51/30mg
Levofl oxacin TabletsAB-Rated to Levaquin® Tablets
68382-0015-18 250mg 50 24 Modifi ed Capsule; White to Off-White; ZC55
68382-0015-01 250mg 100 24 Modifi ed Capsule; White to Off-White; ZC55
68382-0016-18 500mg 50 24 Modifi ed Capsule; White to Off-White; ZC56
68382-0016-01 500mg 100 24 Modifi ed Capsule; White to Off-White; ZC56
68382-0017-18 750mg 50 24 Modifi ed Capsule; White to Off-White; ZC57
68382-0017-01 750mg 100 24 Modifi ed Capsule; White to Off-White; ZC57
Losartan Potassium Tablets, USPAB-Rated to Cozaar® Tablets
68382-0135-06 25mg 30 24 Capsule; White to Off-White; Z/2
68382-0135-16 25mg 90 24 Capsule; White to Off-White; Z/2
68382-0135-10 25mg 1000 12 Capsule; White to Off-White; Z/2
68382-0136-06 50mg 30 24 Capsule; White to Off-White; Z16/Breakline
68382-0136-16 50mg 90 24 Capsule; White to Off-White; Z16/Breakline
68382-0136-10 50mg 1000 12 Capsule; White to Off-White; Z16/Breakline
Losartan Potassium Tablets, USP continued on next page
8 www.zydususa.com
NDC Strength Count Case Description/Imprint Code
Losartan Potassium Tablets, USP (continued)AB-Rated to Cozaar® Tablets
68382-0137-06 100mg 30 24 Capsule; White to Off-White; Z18
68382-0137-16 100mg 90 24 Capsule; White to Off-White; Z18
68382-0137-10 100mg 1000 12 Capsule; White to Off-White; Z18
Meloxicam Tablets, USPAB-Rated to Mobic® Tablets
68382-0050-01 7.5mg 100 24 Round; Yellow; ZC 25
68382-0050-05 7.5mg 500 12 Round; Yellow; ZC 25
68382-0051-01 15mg 100 24 Round; Yellow; ZC 26
68382-0051-05 15mg 500 12 Round; Yellow; ZC 26
Metformin HCl Tablets, USPAB-Rated to Glucophage® Tablets
68382-0758-01 500mg 100 24 Round; White to Off-White; 70/Z
68382-0758-05 500mg 500 12 Round; White to Off-White; 70/Z
68382-0758-10 500mg 1000 12 Round; White to Off-White; 70/Z
68382-0759-01 850mg 100 24 Oval; White to Off-White; 69/Z
68382-0759-05 850mg 500 12 Oval; White to Off-White; 69/Z
68382-0759-10 850mg 1000 12 Oval; White to Off-White; 69/Z
68382-0760-01 1000mg 100 24 Oval; White to Off-White; Bisect, Z 71
68382-0760-05 1000mg 500 12 Oval; White to Off-White; Bisect, Z 71
68382-0760-10 1000mg 1000 12 Oval; White to Off-White; Bisect, Z 71
Mesalamine Delayed-Release Tablets Compare to Asacol® HD Delayed-Release Tablets
68382-0484-28 800mg 180 12 Capsule-shaped; Red-brown; WC 800
Morphine Sulfate Extended-Release TabletsAB-Rated to MS Contin® Extended-Release Tablets
68382-0903-01 15mg 100 24 Oval; Green; N/15
68382-0904-01 30mg 100 24 Oval; Pink; N/30
68382-0905-01 60mg 100 24 Oval; White; N/60
68382-0906-01 100mg 100 24 Oval; Gray; N/100
68382-0907-01 200mg 100 24 Oval; Brown; N/200
9 www.zydususa.com
NDC Strength Count Case Description/Imprint Code
Nateglinide Tablets, USPAB-Rated to Starlix® Tablets
68382-0721-16 60mg 90 24 Round; White to Off-White; 721
68382-0722-16 120mg 90 24 Oval; Light-Orange to Orange; 722
Niacin Extended-Release TabletsSame as Niaspan® Extended-Release Tablets
68382-0201-16 500mg 90 24 Capsule-shaped; Medium-Orange; “a” logo 500
68382-0202-16 750mg 90 24 Capsule-shaped; Medium-Orange; “a” logo 750
68382-0203-16 1000mg 90 24 Oval; Medium-Orange; “a” logo 1000
Omeprazole Delayed-Release Capsules, USPAB-Rated to Prilosec® Capsules
68382-0411-01 10mg 100 24 Capsule; Amethyst Purple/White; ZA-09/10 mg
68382-0412-05 20mg 500 12 Capsule; Tan/White; ZA-10/20 mg
68382-0500-01 40mg 100 24 Capsule; Amethyst Purple/White; ZA-11/40 mg
68382-0500-10 40mg 1000 12 Capsule; Amethyst Purple/White; ZA-11/40 mg
Oxycodone HCl Tablets, USPAB-Rated to Roxicodone® Tablets
68382-0793-01 5mg 100 24 Round; Orange; NP, Partial Bisect/11
68382-0794-01 10mg 100 24 Round; Pink; NP, Partial Bisect/12
68382-0795-01 15mg 100 24 Round; Yellow; NP, Partial Bisect/13
68382-0796-01 20mg 100 24 Round; Gray; NP, Partial Bisect/14
68382-0797-01 30mg 100 24 Round; White; NP, Partial Bisect/15
Paricalcitol CapsulesSame as Zemplar® Capsules
68382-0266-06 1mcg 30 48 Capsule; Gray; “a” logo ZA
68382-0267-06 2mcg 30 48 Capsule; Orange-Brown; “a” logo ZF
10 www.zydususa.com
NDC Strength Count Case Description/Imprint Code
Paroxetine Tablets, USPSame as Paxil® Tablets
68382-0097-06 10mg 30 24 Round; White to Off-White; Bisect, ZC 15
68382-0097-16 10mg 90 24 Round; White to Off-White; Bisect, ZC 15
68382-0097-05 10mg 500 12 Round; White to Off-White; Bisect, ZC 15
68382-0097-10 10mg 1000 12 Round; White to Off-White; Bisect, ZC 15
68382-0098-06 20mg 30 24 Round; White to Off-White; Bisect, ZC 16
68382-0098-16 20mg 90 24 Round; White to Off-White; Bisect, ZC 16
68382-0098-01 20mg 100 24 Round; White to Off-White; Bisect, ZC 16
68382-0098-05 20mg 500 12 Round; White to Off-White; Bisect, ZC 16
68382-0098-10 20mg 1000 12 Round; White to Off-White; Bisect, ZC 16
68382-0099-06 30mg 30 24 Round; White to Off-White; ZC17
68382-0099-16 30mg 90 24 Round; White to Off-White; ZC17
68382-0099-05 30mg 500 12 Round; White to Off-White; ZC17
68382-0099-10 30mg 1000 12 Round; White to Off-White; ZC17
68382-0001-06 40mg 30 24 Round; White to Off-White; ZC18
68382-0001-16 40mg 90 24 Round; White to Off-White; ZC18
68382-0001-05 40mg 500 12 Round; White to Off-White; ZC18
Potassium Chloride Extended-Release Capsules, USPSame as Micro-K® Extencaps® Extended-Release Capsules, USP
68382-0702-01 8mEq (600mg) 100 12 Capsule; Pale Orange; 002/002
68382-0701-01 10mEq (750mg) 100 12 Capsule; Pale Orange/Opaque White; 001/001
68382-0701-05 10mEq (750mg) 500 12 Capsule; Pale Orange/Opaque White; 001/001
Potassium Chloride Extended-Release Tablets, USPSame as K-Tab® Extended-Release Tablets
68382-0776-01 8mEq (600mg) 100 48 Round; Yellow; K-TAB
68382-0776-10 8mEq (600mg) 1000 12 Round; Yellow; K-TAB
68382-0600-01 10mEq (750mg) 100 48 Ovaloid; Yellow; “a”logo/K-TAB
68382-0600-10 10mEq (750mg) 1000 12 Ovaloid; Yellow; “a”logo/K-TAB
68382-0398-01 20mEq (1500mg) 100 48 Ovaloid; White; K-TAB
68382-0398-05 20mEq (1500mg) 500 12 Ovaloid; White; K-TAB
11 www.zydususa.com
NDC Strength Count Case Description/Imprint Code
Potassium Citrate Extended-Release TabletsAB-Rated to Urocit-K® Extended-Release Tablets
68382-0536-01 5mEq 100 24 Round; Tan to Yellowish; 536
68382-0537-01 10mEq 100 24 Oval; Tan to Yellowish; 537
68382-0538-01 15mEq 100 24 Oblong; Tan to Yellowish; 538
Pramipexole Dihydrochloride TabletsAB-Rated to Mirapex® Tablets
68382-0196-16 0.125mg 90 24 Capsule; Pink; P1
68382-0196-10 0.125mg 1000 12 Capsule; Pink; P1
68382-0197-16 0.25mg 90 24 Round; Pale Blue; P2/Bisect
68382-0197-10 0.25mg 1000 12 Round; Pale Blue; P2/Bisect
68382-0198-16 0.5mg 90 24 Capsule; Lavender; P3/Bisect
68382-0198-10 0.5mg 1000 12 Capsule; Lavender; P3/Bisect
68382-0199-16 1mg 90 24 Round; Light Peach to Peach; P4/Bisect
68382-0199-10 1mg 1000 12 Round; Light Peach to Peach; P4/Bisect
68382-0200-16 1.5mg 90 24 Round; Yellow; P5/Bisect
68382-0200-10 1.5mg 1000 12 Round; Yellow; P5/Bisect
Pravastatin Sodium Tablets, USPAB-Rated to Pravachol® Tablets
68382-0070-16 10mg 90 24 Oval; White to Off-White; ZC46
68382-0070-05 10mg 500 12 Oval; White to Off-White; ZC46
68382-0071-16 20mg 90 24 Oval; White to Off-White; ZC45
68382-0071-05 20mg 500 12 Oval; White to Off-White; ZC45
68382-0072-16 40mg 90 24 Oval; White to Off-White; ZC44
68382-0072-05 40mg 500 12 Oval; White to Off-White; ZC44
68382-0073-16 80mg 90 24 Oval; White to Off-White; ZC43
68382-0073-05 80mg 500 12 Oval; White to Off-White; ZC43
Promethazine HCl Tablets, USPAB-Rated to Phenergan® Tablets
68382-0040-01 12.5mg 100 24 Round; White to Off-White; Bisect, ZC 01
68382-0041-01 25mg 100 24 Round; White to Off-White; Quadrisect, Z C 0 2
68382-0041-10 25mg 1000 12 Round; White to Off-White; Quadrisect, Z C 0 2
68382-0042-01 50mg 100 24 Round; White to Off-White; ZC 03
12 www.zydususa.com
NDC Strength Count Case Description/Imprint Code
Pyridostigmine Bromide Tablets, USPAB-Rated to Mestinon® Tablets
68382-0659-01 60mg 100 24 Round; White to Off-White; Quadrisect/659
Ramipril CapsulesAB-Rated to Altace® Capsules
68382-0144-06 1.25mg 30 24 Capsule; White Opaque/Yellow Opaque; ZA-43/1.25 mg
68382-0144-01 1.25mg 100 24 Capsule; White Opaque/Yellow Opaque; ZA-43/1.25 mg
68382-0144-05 1.25mg 500 12 Capsule; White Opaque/Yellow Opaque; ZA-43/1.25 mg
68382-0145-06 2.5mg 30 24 Capsule; White Opaque/Orange Opaque; ZA-44/2.5 mg
68382-0145-01 2.5mg 100 24 Capsule; White Opaque/Orange Opaque; ZA-44/2.5 mg
68382-0145-05 2.5mg 500 12 Capsule; White Opaque/Orange Opaque; ZA-44/2.5 mg
68382-0146-06 5mg 30 24 Capsule; White Opaque/Red Opaque; ZA-45/5 mg
68382-0146-01 5mg 100 24 Capsule; White Opaque/Red Opaque; ZA-45/5 mg
68382-0146-05 5mg 500 12 Capsule; White Opaque/Red Opaque; ZA-45/5 mg
68382-0147-06 10mg 30 24 Capsule; White Opaque/Blue Opaque; ZA-46/10 mg
68382-0147-01 10mg 100 24 Capsule; White Opaque/Blue Opaque; ZA-46/10 mg
68382-0147-05 10mg 500 12 Capsule; White Opaque/Blue Opaque; ZA-46/10 mg
Ribavirin CapsulesAB-Rated to Rebetol® Capsules
68382-0260-12 200mg 84 24 Capsule; White/White; ZA-12/200mg
Ribavirin TabletsAB-Rated to Copegus® Tablets
68382-0046-03 200mg 168 24 Round; Light Pink to Pink; ZC19
Risperidone Tablets, USPAB-Rated to Risperdal® Tablets
68382-0112-14 0.25mg 60 24 Round; Dark Yellow; Z/4
68382-0112-05 0.25mg 500 12 Round; Dark Yellow; Z/4
68382-0113-14 0.5mg 60 24 Round; Red-Brown; Z/6
68382-0113-05 0.5mg 500 12 Round; Red-Brown; Z/6
68382-0114-14 1mg 60 24 Round; White to Off-White; ZC75
68382-0114-05 1mg 500 12 Round; White to Off-White; ZC75
68382-0115-14 2mg 60 24 Round; Orange; ZC76
68382-0115-05 2mg 500 12 Round; Orange; ZC76
Risperidone Tablets, USP continued on next page
13 www.zydususa.com
NDC Strength Count Case Description/Imprint Code
Risperidone Tablets, USP (continued)AB-Rated to Risperdal® Tablets
68382-0116-14 3mg 60 24 Round; Yellow; ZC77
68382-0116-05 3mg 500 12 Round; Yellow; ZC77
68382-0117-14 4mg 60 24 Round; Green; ZC78
68382-0117-05 4mg 500 12 Round; Green; ZC78
Simvastatin Tablets, USPAB-Rated to Zocor® Tablets
68382-0065-16 5mg 90 24 Oval; White; ZA19
68382-0065-10 5mg 1000 12 Oval; White; ZA19
68382-0066-16 10mg 90 24 Oval; Pink; ZA20
68382-0066-05 10mg 500 12 Oval; Pink; ZA20
68382-0066-10 10mg 1000 12 Oval; Pink; ZA20
68382-0067-16 20mg 90 24 Oval; Peach; ZA21
68382-0067-05 20mg 500 12 Oval; Peach; ZA21
68382-0067-10 20mg 1000 12 Oval; Peach; ZA21
68382-0068-16 40mg 90 24 Oval; Pink; ZA22
68382-0068-05 40mg 500 12 Oval; Pink; ZA22
68382-0068-10 40mg 1000 12 Oval; Pink; ZA22
68382-0069-16 80mg 90 24 Capsule; White to Off-White; ZA23
68382-0069-05 80mg 500 12 Capsule; White to Off-White; ZA23
68382-0069-10 80mg 1000 12 Capsule; White to Off-White; ZA23
Sirolimus TabletsAB-Rated to Rapamune® Tablets
68382-0520-01 0.5mg 100 24 Round; Yellow; 1
Sodium Phenylacetate/Sodium Benzoate InjectionAP-Rated to Ammonul® Injection
68382-0396-01 10%/10% 50mL 24 SD vial, 1 vial per carton
Tamsulosin HCl Capsules, USPAB-Rated to Flomax® Capsules
68382-0132-01 0.4mg 100 24 Capsule; Green/Peach; ZA-18/0.4 mg
68382-0132-10 0.4mg 1000 12 Capsule; Green/Peach; ZA-18/0.4 mg
14 www.zydususa.com
NDC Strength Count Case Description/Imprint Code
Telmisartan TabletsAB-Rated to Micardis® Tablets
68382-0471-78 20mg3x10
Blister Pack36 Round; Mottled Light Brown to Mottled Brown; 471
68382-0472-78 40mg3x10
Blister Pack36 Oblong; Mottled Light Brown to Mottled Brown; 472
68382-0473-78 80mg3x10
Blister Pack36 Oblong; Mottled Light Brown to Mottled Brown; 473
Topiramate Capsules (Sprinkle)AB-Rated to Topamax® Sprinkle Capsules
68382-0004-14 15mg 60 24 Capsule; White Opaque/White Opaque; ZA63/15 mg
68382-0005-14 25mg 60 24 Capsule; White Opaque/White Opaque; ZA64/25 mg
Topiramate TabletsAB-Rated to Topamax® Tablets
68382-0138-14 25mg 60 24 Round; White to Off-White; ZD 16
68382-0138-05 25mg 500 12 Round; White to Off-White; ZD 16
68382-0139-14 50mg 60 24 Round; White to Off-White; ZD 15
68382-0139-05 50mg 500 12 Round; White to Off-White; ZD 15
68382-0140-14 100mg 60 24 Round; White to Off-White; ZD 14
68382-0140-05 100mg 500 12 Round; White to Off-White; ZD 14
68382-0141-14 200mg 60 24 Round; White to Off-White; ZD 13
68382-0141-05 200mg 500 12 Round; White to Off-White; ZD 13
Tramadol HCl TabletsAB-Rated to Ultram® Tablets
68382-0319-01 50mg 100 24 Round; White to Off-White; 319
68382-0319-10 50mg 1000 12 Round; White to Off-White; 319
Tramadol HCl/Acetaminophen TabletsAB-Rated to Ultracet® Tablets
68382-0334-01 37.5/325mg 100 24 Capsule-shaped; White; 334
68382-0334-05 37.5/325mg 500 12 Capsule-shaped; White; 334
Venlafaxine HCl Extended-Release CapsulesAB-Rated to Effexor XR® Extended-Release Capsules
68382-0034-06 37.5mg 30 24 Capsule; Grey/White; ZA-35/37.5 mg
68382-0034-16 37.5mg 90 24 Capsule; Grey/White; ZA-35/37.5 mg
68382-0034-10 37.5mg 1000 12 Capsule; Grey/White; ZA-35/37.5 mg
Venlafaxine HCl Extended-Release Capsules continued on next page
15 www.zydususa.com
NDC Strength Count Case Description/Imprint Code
Venlafaxine HCl Extended-Release CapsulesAB-Rated to Effexor XR® Extended-Release Capsules
68382-0035-06 75mg 30 24 Capsule; Peach/White; ZA-36/75 mg
68382-0035-16 75mg 90 24 Capsule; Peach/White; ZA-36/75 mg
68382-0035-10 75mg 1000 12 Capsule; Peach/White; ZA-36/75 mg
68382-0036-06 150mg 30 24 Capsule; Dark Orange/White; ZA-37/150 mg
68382-0036-16 150mg 90 24 Capsule; Dark Orange/White; ZA-37/150 mg
68382-0036-10 150mg 1000 12 Capsule; Dark Orange/White; ZA-37/150 mg
Venlafaxine HCl TabletsAB-Rated to Effexor® Tablets
68382-0018-01 25mg 100 24 Round; Peach; Bisect, ZC 64
68382-0019-01 37.5mg 100 24 Round; Peach; Bisect, ZC 65
68382-0020-01 50mg 100 24 Round; Peach; Bisect, ZC 66
68382-0021-01 75mg 100 24 Round; Peach; Bisect, ZC 67
68382-0101-01 100mg 100 24 Round; Peach; Bisect, ZC 68
Voriconazole TabletsAB-Rated to Vfend® Tablets
68382-0735-06 50mg 30 24 Round; White to Off-White; 735
68382-0736-06 200mg 30 24 Oval; White to Off-White; 736
Zolmitriptan Orally Disintegrating TabletsAB-Rated to Zomig-ZMT® Orally Disintegrating Tablets
68382-0715-86 2.5mg1x6 Blister
Pack72 Round; White/mottled white to cream white; 715
68382-0717-82 5mg1x3 Blister
Pack72 Round; White/mottled white to cream white; 717
16 www.zydususa.com
Therapeutic Category Generic Name Brand
Analgesic Etodolac Extended-Release Tablets Lodine XL® Extended-Release Tablets
Analgesic Indomethacin Capsules, USP Indocin® Capsules
Analgesic Meloxicam Tablets, USP Mobic® Tablets
Analgesic Morphine Sulfate Extended-Release Tablets MS Contin® Extended-Release Tablets
Analgesic Oxycodone HCl Tablets, USP Roxicodone® Tablets
Analgesic Tramadol HCl Tablets Ultram® Tablets
Analgesic Tramadol HCl/Acetaminophen Tablets Ultracet® Tablets
Antiarrhythmic Amiodarone HCl Tablets Cordarone® Tablets
Antibiotic Levofl oxacin Tablets Levaquin® Tablets
Anticonvulsant Divalproex Sodium Capsules (Sprinkle) Depakote® Sprinkle Capsules
Anticonvulsant Divalproex Sodium Delayed-Release Tablets, USP Depakote® Delayed-Release Tablets
Anticonvulsant Divalproex Sodium Extended-Release Tablets Depakote® Extended-Release Tablets
Anticonvulsant Gabapentin Tablets Neurontin® Tablets
Anticonvulsant Lamotrigine Chewable Dispersible Tablets Lamictal® Chewable Dispersible Tablets
Anticonvulsant Topiramate Capsules (Sprinkle) Topamax® Sprinkle Capsules
Anticonvulsant Topiramate Tablets Topamax® Tablets
Antidepressant Paroxetine Tablets, USP Paxil® Tablets
Antidepressant Duloxetine HCl Delayed-Release Capsules Cymbalta® Delayed-Release Capsules
Antidepressant Venlafaxine HCl Extended-Release Capsules Effexor XR® Extended-Release Capsules
Antidepressant Venlafaxine HCl Tablets Effexor® Tablets
Anti-Diabetic Glipizide/Metformin HCl Tablets, USP Metaglip® Tablets
Anti-Diabetic Glyburide Tablets, USP Micronase® Tablets
Anti-Diabetic Glyburide/Metformin HCl Tablets, USP Glucovance® Tablets
Anti-Diabetic Nateglinide Tablets, USP Starlix® Tablets
Antidote Sodium Phenylacetate/Sodium Benzoate Injection Ammonul® Injection
Antifungal Voriconazole Tablets Vfend® Tablets
Antiglaucoma Agent Acetazolamide Extended-Release Capsules Diamox® Sequels
Antihyperlipidemic Fenofi brate Tablets TriCor® Tablets
Antihyperlipidemic Fenofi bric Acid Delayed-Release Capsules Trilipix® Delayed-Release Capsules
Antihyperlipidemic Pravastatin Sodium Tablets, USP Pravachol® Tablets
Antihyperlipidemic Simvastatin Tablets, USP Zocor® Tablets
Antihypertensive Ramipril Capsules Altace® Capsules
Anti-Infective Doxycycline Monohydrate Capsules, USP Monodox® Capsules
Antilipemic Niacin Extended-Release Tablets Niaspan® Extended-Release Tablets
Antimalarial Hydroxychloroquine Sulfate Tablets, USP Plaquenil® Tablets
Antimigraine Zolmitriptan Orally Disintegrating Tablets Zomig-ZMT® Orally Disintegrating Tablets
Antineoplastic Agent Amantadine HCl Capsules, USP Symmetrel® Capsules
Antineoplastic Agent Anastrozole Tablets Arimidex® Tablets
Antiparkinson Agent Pramipexole Dihydrochloride Tablets Mirapex® Tablets
Antipsychotic Haloperidol Tablets, USP Haloperidol Tablets, USP
Antipsychotic Risperidone Tablets, USP Risperdal® Tablets
Antirheumatic, Cytotoxic Azathioprine Tablets, USP Imuran® Tablets
Antitussive Benzonatate Capsules, USP Tessalon® Perles
Antiviral Acyclovir Tablets Zovirax® Tablets
Antiviral Ribavirin Capsules Rebetol® Capsules
Antiviral Ribavirin Tablets Copegus® Tablets
17 www.zydususa.com
Therapeutic Category Generic Name Brand
Anxiolytic Buspirone HCl Tablets, USP BuSpar® Tablets
Benign Prostatic Hypertrophy Agent Tamsulosin HCl Capsules, USP Flomax® Capsules
Cardiovascular Agent Amlodipine Besylate Tablets Norvasc® Tablets
Cardiovascular Agent Atenolol Tablets, USP Tenormin® Tablets
Cardiovascular Agent Carvedilol Tablets Coreg® Tablets
Cardiovascular Agent Isosorbide Mononitrate ER Tablets Imdur® Tablets
Cardiovascular Agent Losartan Potassium Tablets, USP Cozaar® Tablets
Central Nervous System Agent Donepezil HCl Orally Disintegrating Tablets Aricept ODT®
Central Nervous System Stimulant Dextroamphetamine Sulfate Tablets, USP Dextrostat®
Cholinesterase Inhibitor Galantamine HBr Tablets, USP Razadyne® Tablets
Cholinesterase Inhibitor Pyridostigmine Bromide Tablets, USP Mestinon® Tablets
Electrolyte Supplement Potassium Chloride Extended-Release Capsules, USPMicro-K® Extencaps® Extended-Release Capsules,
USP
Electrolyte Supplement Potassium Chloride Extended-Release Tablets, USP K-Tab® Extended-Release Tablets
Gastric Acid Secretion Inhibitor Famotidine for Oral Suspension, USP Pepcid® for Oral Suspension
Gastrointestinal Agent Lansoprazole Delayed-Release Capsules, USP Prevacid® Delayed-Release Capsules
Gastrointestinal Agent Mesalamine Delayed-Release Tablets Compare to Asacol® HD Delayed-Release Tablets
Gastrointestinal Agent Omeprazole Delayed-Release Tablets, USP Prilosec® Capsules
Gastrointestinal Agent Promethazine HCl Tablets, USP Phenergan® Tablets
General Anesthetic Etomidate Injection, USP Amidate® Injection
Hypoglycemic Metformin HCl Tablets, USP Glucophage® Tablets
Immune Suppressant Sirolimus Tablets Rapamune® Tablets
Urinary Tract Alkalinizer Potassium Citrate Extended-Release Tablets Urocit-K® Extended-Release Tablets
Vitamin D Analog Paricalcitol Capsules Zemplar® Capsules
18 www.zydususa.com
Ordering Information
Customer ServiceZydus Pharmaceuticals (USA) Inc.
N114 W18850 Clinton Drive
Germantown, WI 53022
Hours of Operation: 8:00 AM – 7:00 PM CST
Phone: 877-ZYDUS RX, Prompt 1 (877-993-8779, Prompt 1)
Fax: 877-993-9055
Remit To1 EAB Plaza
P.O. Box #10004
Uniondale, NY 11555-10004
Minimum Order RequirementsThe minimum order for each SKU is one case pack (usually a quantity of 12, 24, or 48). The total order must exceed $1,000.00.
All orders will be shipped on a prepaid basis utilizing the method of transportation selected by Zydus Pharmaceuticals. In cases
where customer requests are expedited, more expensive, or special handling of an order, Zydus Pharmaceuticals reserves the right
to charge the customer for these expenses.
ReturnsPlease refer to the following page or the Zydus website, www.zydususa.com, for the current Return Goods Policy.
19 www.zydususa.com
Zydus Pharmaceuticals (USA) Inc. Return Goods Policy
This return goods policy applies to all ZyGeneric (68382) and Nesher (51477) labeled pharmaceutical products. All ZyGeneric and
Nesher product returns must be sent prepaid to our designated return goods processor to the following address: Inmar - South Dock, 4332 Empire Road, Fort Worth, TX 76155. Zydus does not pay fees such as processing charges for returning any
product other than recalled product. For customers using other return companies for processing and destruction Zydus will not
assume responsibility for charges incurred.
Request for Return Authorizations (box labels) can be made by any of the below methods:1. Accessing the Inmar website at https://clsnetlink.com (you will need to upload a PDF copy of your debit memo)
2. E-mail your debit memo to [email protected]. Be sure to include NDC#, lot# and expiration dates assigned to each item.
3. Fax your debit memo to Inmar at 817-868-5343
Returnable Items (For Reimbursement):• Products within six (6) months of expiration date and up to 12 months after the expiration date stated on the package.
• Products must be in sealed, full, unopened, original Zydus or Nesher containers.
• Products received in error or damaged in shipping to consignee (accompanied by a signed bill of lading noting such
damage) if reported to Zydus customer service within 5 days of receipt and returned within 30 days.
• Prior written approval is required for all return of all overstocked product with greater than 12 months expiration dating.
This merchandise will be subject to a 15% restocking fee.
• A DEA Form 222 is required in order to return C-II controlled substances. Please send DEA Form 222 requests to:
Fax #(817) 868-5342 or E-mail: [email protected]
Returnable Items (No Credit):• Products returned without an approved Product Return Form.
• Products sold on a non-returnable basis, professional sample, or free goods.
• Partial or open bottles, except where required by law.
• Product which has been repackaged, product purchased through a bankruptcy sale, fi re sale, distress merchandise, or product not in original container are not eligible for credit. Zydus will not credit for product damaged due to insurable causes such as fi re, fl oods or earthquake.
• Products with broken seals, opened, coded, dated, damaged or missing label, or soiled packages.
• Products damaged at customers warehouse or store, or not stored under proper conditions.
• Products with greater than six months expiration dating or are greater than 12 months past the expiration date.
• Private label products.
• Return of over stocked product without prior written approval of Zydus
• Merchandise distributed contrary to federal, state or local laws.
• Product not purchased from either Zydus or the customer’s authorized distributor / wholesaler.
Valuation of Returns:• Direct buying customers will be issued a credit by Zydus. This credit will be issued at the lowest of either original
invoice price or the prevailing contract price on the date the goods are returned to Zydus.
• Non-Direct customers will receive credit directly from Inmar. If no contract exists, the credit will be issued based upon the
lower of the current Zydus standard market price at the time the returned merchandise is received by Inmar OR the original
Zydus contract price at point of purchase from the wholesaler.
Transportation Charges• Prepaid by customer, unless shipped in error by Zydus.
• Returned product shipped collect will be refused.
20 www.zydususa.com
Miscellaneous:• Representatives cannot authorize return of in date product or pick up merchandise.
• Returned products will be promptly evaluated and credit will refl ect eligibility and / or ineligibility. All products returned, whether eligible for credit or not, become property of Zydus. All products are returned with the understanding that they are subject to fi nal review and evaluation by Zydus, and will be processed in accordance with the most recent return policy in effect at the time of the return.
• Wholesalers are not authorized to accept returns of Zydus products except in the case of mis-shipments or other ordering errors.
• Return chargebacks will be paid on original invoice date.
• Zydus reserves the right to amend this policy at any time.
• Claim merchandise-even exchange or credit will be allowed for loss or damage evident at delivery time if noted on the
carrier’ delivery receipt and reported to us within fi ve days. Concealed loss or damage must be inspected by carrier within 15 days after delivery and carrier’s inspection report must be forwarded to Zydus USA.
• Zydus USA policy strictly prohibits any sales representative or any other employee from giving samples or stock packages to any customer to replace merchandise. All returns must be made according to this return goods policy.
Revised Effective 04/15/2015
Zydus Pharmaceuticals (USA) Inc. Return Goods Policy (continued)
21 www.zydususa.com
Contact Information
Address Zydus Pharmaceuticals USA Inc. 73 Route 31 North Pennington, NJ 08534
Telephone 609-730-1900
Fax 609-730-1998
Website www.zydususa.com
Customer Service
Telephone 877-993-8779, Prompt 1
Fax 877-993-9055
Email [email protected]
Medical Affairs Telephone 877-993-8779, Prompt 2
Fax 678-581-4401
Email [email protected]
Returns Inmar 800-967-5952
Zydus Pharmaceuticals USA Inc.73 Route 31 NorthPennington, NJ 08534Phone: 609-730-1900Fax: 609-730-1998www.zydususa.com